Comprehensive Oncology Rehabilitation and Exercise (CORE) Program for Breast Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Huntsman Cancer Institute, Salt Lake City, UTBreast CancerComprehensive Oncology Rehabilitation and Exercise (CORE) Program - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing a new cancer rehab program to see if it is feasible and acceptable. It also aims to see if it is better than the standard of care at getting people to exercise and improving physical function and quality of life.

Eligible Conditions
  • Breast Cancer

Treatment Effectiveness

Study Objectives

2 Primary · 3 Secondary · Reporting Duration: Upon completion of 24-weeks post-surgery SOC visit for participants and about one year post-implementation (approximately 1 year into data collection)

Measured at Post-Diagnosis/Pre-Surgery assessment
Percentage of participants who complete in-clinic assessment
Percentage of participants who complete their referral
Week 24
Change in exercise engagement assessed via accelerometer
Change in exercise engagement assessed via modified Godin survey
Year 1
Percentage of themes identified from focus groups that contain positive feedback

Trial Safety

Trial Design

2 Treatment Groups

Standard of Care (SOC)
1 of 2
Comprehensive Oncology Rehabilitation and Exercise (CORE) Program
1 of 2

Active Control

Experimental Treatment

72 Total Participants · 2 Treatment Groups

Primary Treatment: Comprehensive Oncology Rehabilitation and Exercise (CORE) Program · No Placebo Group · N/A

Comprehensive Oncology Rehabilitation and Exercise (CORE) Program
Behavioral
Experimental Group · 1 Intervention: Comprehensive Oncology Rehabilitation and Exercise (CORE) Program · Intervention Types: Behavioral
Standard of Care (SOC)NoIntervention Group · 1 Intervention: Standard of Care (SOC) · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: upon completion of 24-weeks post-surgery soc visit for participants and about one year post-implementation (approximately 1 year into data collection)

Who is running the clinical trial?

University of UtahLead Sponsor
1,008 Previous Clinical Trials
1,787,310 Total Patients Enrolled
12 Trials studying Breast Cancer
5,567 Patients Enrolled for Breast Cancer

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

Has recruitment for this trial begun yet?

"The available information from clinicaltrials.gov indicates that this trial is still open to participants, having been initially posted on March 24th 2021 and last updated on May 17th 2022." - Anonymous Online Contributor

Unverified Answer

How many participants are being admitted to this research endeavor?

"Affirmative. The information on clinicaltrials.gov suggests that this trial, which was initially published on March 24th 2021, is still actively recruiting participants. 72 individuals need to be accepted from a single medical centre." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.